Ugh. Not the news I was hoping to read this morning. Wonder how much we go down once we resume trading. My guess is $2-$2.50/share. Certainly hope it is not worse than that! Would love for it to go down less than $2/share. Certainly will kill whatever momentum we may have had in script growth. Hopefully prescribing doctors won't lose any confidence in the product... sales team is going to be busy trying to keep the confidence up of prescribers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.